Abstract
AimsProgesterone receptor (PR) is a crucial prognostic marker in breast cancer. However, achieving consistent results in PR immunohistochemistry (IHC) remains challenging due to the lack of well-defined low-positive controls. This...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have